Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease

NCT02148718 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Crohn's Disease

Interventions

BIOLOGICAL: adalimumab

Sponsor

AbbVie

Collaborators

[object Object]
[object Object]